Skip to main content
. 2020 Nov 14;35(12):2832–2849. doi: 10.1093/humrep/deaa250

Table V.

Recorded complications after ART.

EIM
ANZARD
Year OHSS Haemorrhage Infection Foetal reduction Maternal death OHSS Foetal reduction
1997 18
1998 153 (1.1) 6
1999 1083 (0.6) 84 (0.04) 30 (0.02) 121 (0.7)
2000 1586 (0.8) 388 (0.19) 36 (0.02) 256 0 113 (0.7) 14
2001 1851 (0.9) 394 (0.19) 24 (0.01) 391 1
2002 2148 (0.9) 622 (0.26) 227 (0.09) 461 2 192 (1.1) 58
2003 2646 (1.1) 799 (0.29) 135 (0.05) 480 2 218 (1.1) 50
2004 2858 (1.1) 520 (0.20) 362 (0.14) 526 4 300 (1.4) 49
2005 3347 (1.1) 523 (0.17) 207 (0.07) 436 0 306 (1.2) 60
2006 2753 (0.8) 544 (0.16) 42 (0.01) 466 2 240 (0.9) 76
2007 2470 (0.7) 574 (0.17) 64 (0.02) 364 3 244 (0.8)
2008 2947 (0.6) 652 (0.13) 49 (0.01) 394 1 198 (0.6)
2009 2137 (0.6) 415 (0.11) 61 (0.02) 484 1 259 (0.7)
2010 1500 (0.4) 641 (0.17) 53 (0.01) 441 2 206 (0.6)
2011 1705 (0.5) 711 (0.17) 59 (0.01) 343 1 229 (0.7) 99
2012 1953 (0.5) 848 (0.20) 101 (0.02) 485 3 266 (0.7) 105
2013 1845 (0.4) 793 (0.18) 78 (0.02) 416 2 294 (0.7) 106
2014 2039 (0.4) 919 (0.19) 108 (0.02) 526 3 274 (0.7) 94
2015 2167 (0.4) 946 (0.19) 114 (0.02) 501 2 211 (0.5) 115
2016 1928 (0.4) 983 (0.19) 117 (0.02) 553 0 215 (0.5) 177

CDC did not deliver any numbers on adverse events occurring in the USA.